https://www.selleckchem.com/pr....oducts/GDC-0980-RG74
In this study, the correlation between the circulating tumor cells (CTCs), clinical and pathological status, Beclin1 expression, and the prognosis of patients with renal cell carcinoma were studied. The patients with renal cancer were tested every 3 months for 2 years, and once every 6 months after 2 years by using CanPatrol-ITMCTCs detection technology. The expression of Beclin1 in different types of CTCs was detected. The study investigated the correlation between Beclin1 expression of patients with different gender, age, tumo